Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-005222

Director acquired 1,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Galante Joseph C Director 2024-03-25 Grant or award +1,000 $1.71 $1,710 59,356 D
Loading xslF345X05/marketforms-65375.xml…